DOI QR코드

DOI QR Code

Frequency of Cigarette Smoking Among Psychiatric Inpatients Evaluated by the Fagerstrom Test for Nicotine Dependence

  • Published : 2013.01.31

Abstract

Background: In this study our aim was to determine the rate of smoking in a sample of psychiatric in-patients with diagnoses of schizophrenia, bipolar disorder and major depression and to examine factors related to smoking status and the level of dependence in this population. Materials and Methods: A total of 160 people were included in this descriptive study. 80 were inpatients with schizophrenia, bipolar disorder and major depression and 80 people without any psychiatric diagnoses were included as a control group. The participants were interviewed face-to face using a semi-structured questionnaire and Fagerstrom Test for Nicotine Dependence was used to define smoking habits. Results: The mean age of the participants was $37.24{\pm}12.19$ years ranging from 18 to 81 years, 54.4% of the participants were (n=87) female, and 45.6% cases (n=73) were male. 70% (n=56) of the patients and 55% of the control group were smoking and the difference was statistically significant (p<0.01). Total score of Fagerstrom Test for Nicotine Dependence in the patient group was statistically significantly higher than in the control group (p<0.01). Conclusions: In our sample, the frequency of cigarette smoking and nicotine dependence among psychiatric inpatients was high, posing a high risk for smoking related diseases including cancers; therefore there should be counseling on tobacco control and smoking cessation programming targeting this population.

References

  1. GATS (2008). T.C. Saglik Bakanligi Temel Saglik Hizmetleri Genel Mudurlugu, "Kuresel Yetiskin Tutun Arastirmasi Turkiye Raporu". TUlK, Ankara. (in Turkish).
  2. Goff DC, Sullivan LM, McEvoy JP, et al (2005). A comparison of ten-year cardiac risk estimates in schizophrenia patients from the CATIE study and matched controls. Schizophr Res, 80, 45-53. https://doi.org/10.1016/j.schres.2005.08.010
  3. Hennekens CH, Hennekens AR, Hollar D, et al (2005). Schizophrenia and increased risks of cardiovascular disease. Am Heart J, 150, 1115-21. https://doi.org/10.1016/j.ahj.2005.02.007
  4. Kelly C, McCreadie RG (1999). Smoking habits, current symptoms and premorbid characteristics of schizophrenic patients in Nithsdale, Scotland. Am J Psychiatry, 156, 1751-7.
  5. Kilian R, Becker T, Kruger K, et al (2006). Health behavior in psychiatric in-patients compared with a German general population sample. Acta Psychiatr Scand, 114, 242-8. https://doi.org/10.1111/j.1600-0447.2006.00850.x
  6. Ogel K, Tamar D, Ozmen E, et al (2003). lstanbul Ornekleminde Tutun (Sigara) Kullanim Yayginligi. J Dependence, 4, 105-8.
  7. Osborn DPJ, King MB, Nazareth I (2003). Participation in screening for cardiovascular risk by people with schizophrenia or similar mental illness: cross sectional study in general practice. BMJ, 326, 1122-3. https://doi.org/10.1136/bmj.326.7399.1122
  8. PIAR (1988). Sigara Aliskanliklari ve Sigara ile Mucadele Kampanyasi Kamuoyu Arastirma Raporu. Istanbul (in Turkish).
  9. Salokangas RKR, Honkonen T, Stengard E, et al (2006). Cigarette smoking in long-term schizophrenia. Eur Psychiatry, 21, 219-3. https://doi.org/10.1016/j.eurpsy.2005.07.008
  10. Strassnig M, Brar JS, Ganguli R (2006). Increased caffeine and nicotine consumption in community-dwelling patients with schizophrenia. Schizophr Res, 86, 269-5. https://doi.org/10.1016/j.schres.2006.05.013
  11. Uysal MA, Kadakal F, Karsidag C, et al (2004). Fagerstrom test for nicotine dependence: reliability in a Turkish sample and factor analysis. Tuberk Toraks, 52, 115-21.
  12. Williams JM, Ziedonis D (2004) Addressing tobacco among individuals with a mental illness or an addiction. Addict Behav, 29, 1067-83. https://doi.org/10.1016/j.addbeh.2004.03.009
  13. American Psychiatric Association (1994). Diagnostic and statistical manual of mental disorders (4th ed) (DSM-IV), Washington, DC: APA.
  14. Brown S, Inskip H, Barraclough B (2000). Causes of the excess mortality of schizophrenia. Br J Psychiatry, 177, 212-7. https://doi.org/10.1192/bjp.177.3.212
  15. Chaves L, Shirakawa I (2008). Nicotine use in patients with schizophrenia evaluated by the fagerström tolerance questionnaire: a descriptive analysis from a Brazilian sample. Rev Bras Psiquiatr, 30, 350-2. https://doi.org/10.1590/S1516-44462008005000014
  16. Filik R, Sipos A, Kehoe PG, et al (2006). The cardiovascular and respiratory health of people with schizophrenia. Acta Psychiatr Scand, 113, 298-05. https://doi.org/10.1111/j.1600-0447.2006.00768.x

Cited by

  1. Cochlear implant candidates with psychogenic hearing loss vol.135, pp.4, 2015, https://doi.org/10.3109/00016489.2014.985801
  2. Work-Associated Stress and Nicotine Dependence among Law Enforcement Personnel in Mangalore, India vol.17, pp.2, 2016, https://doi.org/10.7314/APJCP.2016.17.2.829
  3. Regional Homogeneity Changes in Nicotine Addicts by Resting-State fMRI vol.12, pp.1, 2017, https://doi.org/10.1371/journal.pone.0170143
  4. A Systematic Review of Psychosocial Barriers and Facilitators to Smoking Cessation in People Living With Schizophrenia vol.9, pp.1664-0640, 2018, https://doi.org/10.3389/fpsyt.2018.00565